Dissemination of clinical trial results by leading academic medical centres in the United States remains poor, despite ethical obligations – and sometimes statutory requirements – to publish findings and report results in a timely manner, concludes a study in The BMJ this week. Researchers found that only 29% of completed clinical trials led by investigators at major US academic centers were published within two …